STOCK TITAN

Dolby Laboratories Reports Fourth Quarter and Fiscal 2020 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Dolby Laboratories (NYSE:DLB) reported its fourth quarter and fiscal year results for 2020, highlighting total revenue of $271.2 million in Q4, down from $298.8 million in Q4 2019. Full-year revenue was $1.16 billion, compared to $1.24 billion in the previous year. GAAP net income for Q4 was $26.8 million ($0.26 per share), down from $43.9 million in Q4 2019. Outlook remains uncertain due to COVID-19, affecting royalties and operational results. A cash dividend of $0.22 per share has been declared.

Positive
  • Declared cash dividend of $0.22 per share.
Negative
  • Q4 revenue decreased by 9.3% year-over-year.
  • GAAP net income for Q4 fell by 39% compared to Q4 2019.
  • Fiscal 2020 net income declined to $231.4 million from $255.2 million in fiscal 2019.
  • COVID-19 is impacting revenue across various markets.
  • Uncertainty in future results due to the pandemic.

SAN FRANCISCO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the fourth quarter and fiscal year that ended September 25, 2020. For the fourth quarter, Dolby reported total revenue of $271.2 million, compared to $298.8 million for the fourth quarter of fiscal 2019. For fiscal 2020, Dolby reported total revenue of $1.16 billion, compared to $1.24 billion for fiscal 2019.

“Dolby experiences are expanding to a broader range of content,” said Kevin Yeaman, President and CEO, Dolby Laboratories. “With the launch of iPhone 12, consumers are now able to create in Dolby Vision and we are also beginning to address content experiences and interactions within new use cases and industries as we enable developers through Dolby.io.”

Fourth quarter GAAP net income was $26.8 million, or $0.26 per diluted share, compared to GAAP net income of $43.9 million, or $0.43 per diluted share for the fourth quarter of fiscal 2019. On a non-GAAP basis, fourth quarter net income was $45.8 million, or $0.45 per diluted share, compared to $67.6 million, or $0.66 per diluted share for the fourth quarter of fiscal 2019. Fourth quarter cash flows from operations was $112.7 million, compared to $130.5 million for the fourth quarter of fiscal 2019. A complete listing of Dolby's non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release. 

Fiscal 2020 GAAP net income was $231.4 million, or $2.25 per diluted share, compared to $255.2 million, or $2.44 per diluted share for fiscal 2019. On a non-GAAP basis, fiscal 2020 net income was $305.2 million, or $2.97 per diluted share, compared to $334.6 million, or $3.20 per diluted share, for fiscal 2019. Fiscal 2020 cash flows from operations was $343.8 million, compared to $327.7 million for fiscal 2019.

COVID-19

Dolby continues to monitor the COVID-19 pandemic and its impact on our company. Our priorities continue to be the safety and well-being of our employees and supporting our communities. Since the initial outbreak of COVID-19, our revenues have been, and we expect will continue to be, impacted across various markets within licensing and products and services. The implications of COVID-19 on our future results of operations remain uncertain.

We expect continued significant uncertainty in global financial markets. Dolby’s financial results for the fourth quarter of fiscal 2020 rely on estimates of royalty-based revenue that take into consideration the macroeconomic effect of global events, including the COVID-19 pandemic, which may impact supply chain activities and demand for shipments. For more information, see the section captioned “Critical Accounting Policies and Estimates” in our most recently filed Quarterly Report on Form 10-Q.

Dividend

Today, Dolby announced a cash dividend of $0.22 per share of Class A and Class B common stock, payable on December 4, 2020, to stockholders of record as of the close of business on November 24, 2020.

Financial Outlook - First and Second Quarters Fiscal 2021

Unit volume shipments, aggregated across various end markets and devices, continue to be impacted and difficult to predict because of economic uncertainty due to COVID-19, and it remains unclear when such unit volumes could return to pre-pandemic levels. The global cinema market has been adversely impacted by COVID-19 because of site closures or reduced utilization, and we anticipate that cinema sites could continue to be negatively affected through the first half of fiscal 2021 or longer.

Our actual results could differ materially from the estimates we are providing due in part to the challenging economic environment and highly uncertain effects of COVID-19. The estimates we are providing for future periods reflect certain assumptions about the potential impact of COVID-19, based upon a consideration of external and internal data and information. For more information, see "Forward-Looking Statements" in this press release for a description of certain risks that we face, and the section captioned “Risk Factors” in our most recently filed Quarterly Report on Form 10-Q.

First Quarter Fiscal 2021

Dolby is providing the following estimates for its first quarter of fiscal 2021:

  • Total revenue is estimated to range from $330 million to $360 million

  • Gross margin percentages are anticipated to range from 90% to 91% on a GAAP basis and from 91% to 92% on a non-GAAP basis

  • Operating expenses are anticipated to range from $207 million to $219 million on a GAAP basis and from $175 million to $185 million on a non-GAAP basis

  • Effective tax rate is anticipated to range from 20% to 21% on both a GAAP and non-GAAP basis

  • Diluted earnings per share is anticipated to range from $0.70 to $0.85 on a GAAP basis and from $0.97 to $1.12 on a non-GAAP basis

Second Quarter Fiscal 2021

Dolby is also providing the following estimate for its second quarter of fiscal 2021:

  • Total revenue is estimated to range from $270 million to $300 million

Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss fourth quarter and fiscal 2020 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, November 12, 2020. Access to the teleconference will be available over the Internet from http://investor.dolby.com/event-calendar or by dialing 1-800-289-0438. International callers can access the conference call at 1-323-794-2423.

A replay of the call will be available from 5:00 p.m. PT on Thursday, November 12, 2020, until 8:59 p.m. PT on Thursday, November 19, 2020, by dialing 1-844-512-2921 (international callers can access the replay by dialing 1-412-317-6671) and entering the confirmation code 5368845. An archived version of the teleconference will also be available on the Dolby website, http://investor.dolby.com.

Non-GAAP Financial Information

To supplement Dolby's financial statements presented on a GAAP basis, Dolby provides certain non-GAAP financial measures to provide investors with an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations. Specifically, we exclude the following as adjustments from one or more of our non-GAAP financial measures:

Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that we grant. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between our underlying operating results and those of other companies, we exclude stock-based compensation expense.

Amortization of acquisition-related intangibles: We amortize intangible assets acquired in connection with acquisitions. These intangible assets consist of patents and technology, customer relationships, and other intangibles. We record amortization charges relating to these intangible assets in our GAAP financial statements, and we view these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of our acquisitions. As these amortization charges do not directly correlate to our operations during any particular period, and often remain unchanged between reporting periods, we exclude these charges to facilitate an evaluation of our current operating results and comparisons to our past operating performance.

Restructuring charges: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. We exclude restructuring costs, including any adjustments to charges recorded in prior periods, as we believe that these costs are not representative of our normal operating activities and therefore, excluding these amounts enables a more effective comparison to our past operating performance.

Income tax adjustments: We believe that excluding the income tax effect of the aforementioned non-GAAP adjustments provides a more accurate view of our underlying operating results to management and investors.

Impact from Tax Reform: The enactment of the U.S. Tax Cuts and Jobs Act (Tax Reform), and any related amendments or revisions, requires certain discrete and infrequent charges that are not representative of current operating results and therefore, excluding these amounts enables a more effective comparison to our past operating performance.

Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby's management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby's business. Dolby's management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.

Forward-Looking Statements

Certain statements in this press release, including, but not limited to, statements relating to Dolby's expected financial results for the first and second quarters of fiscal 2021, our ability to advance our long-term objectives, and future dividend payments are "forward-looking statements" that are subject to risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of the COVID-19 pandemic on Dolby’s business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; consumer demand for products that incorporate Dolby technologies; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; the impact to the overall cinema market, including closures or limitations of cinema capacity and resulting adverse impact to Dolby’s revenue recognized on box-office sales and demand for cinema products and services; temporary Dolby office closures and other actions to protect Dolby’s workforce; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with trends in the markets in which Dolby operates, including the Broadcast, Mobile, Consumer Electronics, PC, Cinema, and Other Markets; the loss of, or reduction in sales by, a key customer or licensee; pricing pressures; risks that the continued shift in content distribution from optical disc-based and other traditional media to online and streaming media content could result in fewer devices with Dolby technologies or less revenue from such devices; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to the expiration of patents; the timing of Dolby's receipt of royalty reports and payments from its licensees, including recoveries; changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements; Dolby's ability to develop, maintain, and strengthen relationships with industry participants; Dolby's ability to develop and deliver innovative technologies in response to new and growing markets; competitive risks; risks associated with conducting business in China and other countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture industry generally; Dolby's ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond audio technologies to other technologies; risks associated with acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby's SEC filings and reports, including the risks identified under the section captioned "Risk Factors" in our most recent quarterly report on Form 10-Q. Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby Laboratories

Dolby Laboratories (NYSE: DLB) is based in San Francisco with offices in over 20 countries around the globe. Dolby transforms the science of sight and sound into spectacular experiences. Through innovative research and engineering, we create breakthrough experiences for billions of people worldwide through a collaborative ecosystem spanning artists, businesses, and consumers. The experiences people have - with Dolby Cinema, Dolby Vision, Dolby Atmos, Dolby Audio, and Dolby Voice - revolutionize entertainment and communications at the cinema, on the go, in the home, and at work. 

Dolby, Dolby Cinema, Dolby Vision, Dolby Atmos, Dolby Audio, Dolby Voice, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories, Inc. in the United States and/or other countries. Other trademarks remain the property of their respective owners. DLB-F




DOLBY LABORATORIES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts; unaudited)

 Fiscal Quarter Ended Fiscal Year-To-Date Ended
 September 25,
2020
September 27,
2019
 September 25,
2020
September 27,
2019
Revenue:     
Licensing$256,904  $264,796   $1,078,577  $1,107,280  
Products and services14,287  34,031   83,215  134,340  
Total revenue271,191  298,827   1,161,792  1,241,620  
      
Cost of revenue:     
Cost of licensing12,665  16,770   50,822  57,531  
Cost of products and services29,800  29,190   95,676  103,323  
Total cost of revenue42,465  45,960   146,498  160,854  
      
Gross margin228,726  252,867   1,015,294  1,080,766  
      
Operating expenses:     
Research and development61,726  60,191   239,045  237,871  
Sales and marketing81,396  82,149   335,933  343,835  
General and administrative55,581  53,013   219,753  205,425  
Restructuring charges/(credits)(45) 6,294   1,821  36,558  
Total operating expenses198,658  201,647   796,552  823,689  
      
Operating income30,068  51,220   218,742  257,077  
      
Other income/expense:     
Interest income494  5,689   12,725  24,919  
Interest expense(55) (64)  (186) (170) 
Other income/(expense), net3,985  (594)  8,434  481  
Total other income4,424  5,031   20,973  25,230  
      
Income before income taxes34,492  56,251   239,715  282,307  
Provision for income taxes(7,516) (12,316)  (8,096) (26,802) 
Net income including controlling interest26,976  43,935   231,619  255,505  
Less: net (income) attributable to controlling interest(147) (17)  (256) (354) 
Net income attributable to Dolby Laboratories, Inc.$26,829  $43,918   $231,363  $255,151  
      
Net income per share:     
Basic$0.27  $0.44   $2.30  $2.51  
Diluted$0.26  $0.43   $2.25  $2.44  
Weighted-average shares outstanding:     
Basic100,473  100,481   100,564  101,629  
Diluted102,722  102,945   102,944  104,572  




DOLBY LABORATORIES, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands; unaudited)

 September 25,
2020
September 27,
2019
ASSETS  
Current assets:  
Cash and cash equivalents$1,071,876  $797,210  
Restricted cash8,103  8,383  
Short-term investments46,948  119,146  
Accounts receivable, net180,340  189,115  
Contract assets161,357  195,651  
Inventories, net25,550  32,331  
Prepaid expenses and other current assets53,022  39,704  
Total current assets1,547,196  1,381,540  
Long-term investments52,149  179,587  
Property, plant, and equipment, net541,963  537,432  
Operating lease right-of-use assets76,515    
Goodwill and intangible assets, net489,376  515,720  
Deferred taxes118,881  114,075  
Other non-current assets91,245  93,395  
Total assets$2,917,325  $2,821,749  
   
LIABILITIES AND STOCKHOLDERS’ EQUITY  
Current liabilities:  
Accounts payable$12,617  $15,212  
Accrued liabilities219,974  268,144  
Income taxes payable3,260  3,506  
Contract liabilities15,436  19,991  
Operating lease liabilities15,822    
Total current liabilities267,109  306,853  
Non-current contract liabilities24,342  24,404  
Non-current operating lease liabilities65,315    
Other non-current liabilities122,154  177,462  
Total liabilities478,920  508,719  
   
Stockholders’ equity:  
Class A common stock58  58  
Class B common stock41  41  
Retained earnings2,443,138  2,327,877  
Accumulated other comprehensive (loss)(10,594) (20,625) 
Total stockholders’ equity – Dolby Laboratories, Inc.2,432,643  2,307,351  
Controlling interest5,762  5,679  
Total stockholders’ equity2,438,405  2,313,030  
Total liabilities and stockholders’ equity$2,917,325  $2,821,749  




DOLBY LABORATORIES, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands; unaudited)

 Fiscal Year-To-Date Ended
 September 25,
2020
September 27,
2019
Operating activities:  
Net income including controlling interest$231,619  $255,505  
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation and amortization90,878  85,123  
Stock-based compensation86,628  76,580  
Amortization of premium on investments800  358  
Provision for doubtful accounts7,689  4,523  
Deferred income taxes(5,274) (40,191) 
Restructuring charge for exit of leased facility1,640  33,251  
Other non-cash items affecting net income10,920  6,952  
Changes in operating assets and liabilities:  
Accounts receivable, net1,251  (27,492) 
Contract assets34,297  (29,708) 
Inventories(11,784) (16,098) 
Operating lease right-of-use assets(13,516)   
Prepaid expenses and other assets(5,680) (6,200) 
Accounts payable and accrued liabilities(45,185) 169  
Income taxes, net(50,586) (2,186) 
Contract liabilities(4,621) 1,084  
Operating lease liabilities15,618    
Other non-current liabilities(845) (13,996) 
Net cash provided by operating activities343,849  327,674  
   
Investing activities:  
Purchases of investment securities(287,777) (265,361) 
Proceeds from sales of investment securities244,517  200,636  
Proceeds from maturities of investment securities246,621  136,951  
Purchases of property, plant, and equipment(66,347) (96,281) 
Payments for business acquisitions, net of cash acquired  (14,919) 
Purchase of intangible assets(2,640) (17,255) 
Net cash provided by/(used in) investing activities134,374  (56,229) 
   
Financing activities:  
Proceeds from issuance of common stock82,658  57,346  
Repurchase of common stock(173,742) (340,585) 
Payment of cash dividend(88,581) (77,496) 
Distribution to controlling interest(283) (1,015) 
Shares repurchased for tax withholdings on vesting of restricted stock(23,065) (22,788) 
Payment related to prior purchases of intangible assets(91)   
Payment of deferred consideration for prior business combination(4,671) (743) 
Net cash used in financing activities(207,775) (385,281) 
   
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash3,938  (5,821) 
Net increase/(decrease) in cash, cash equivalents, and restricted cash274,386  (119,657) 
Cash, cash equivalents, and restricted cash at beginning of period805,593  925,250  
Cash, cash equivalents, and restricted cash at end of period$1,079,979  $805,593  




GAAP to Non-GAAP Reconciliations
(in millions, except per share data; unaudited)
      
The following tables present Dolby's GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the fourth quarter of fiscal 2020 and 2019 and fiscal 2020 and 2019:
      
Net income:Fiscal Quarter Ended Fiscal Year Ended
 September 25,
2020
September 27,
2019
 September 25,
2020
September 27,
2019
GAAP net income$26.8  $43.9   $231.4  $255.2  
Stock-based compensation (1)21.8  17.0   86.7  76.6  
Amortization of acquisition-related intangibles (2)2.5  3.1   10.7  9.9  
Restructuring charges  6.3   1.9  36.5  
Impact of Tax Reform       (18.2) 
Income tax adjustments(5.3) (2.7)  (25.5) (25.4) 
Non-GAAP net income$45.8  $67.6   $305.2  $334.6  
      
(1) Stock-based compensation included in above line items:        
Cost of products and services0.5  0.4   2.0  1.7  
Research and development6.3  5.3   25.7  23.2  
Sales and marketing8.2  5.8   32.0  28.1  
General and administrative6.8  5.5   27.0  23.6  
            
(2) Amortization of acquisition-related intangibles included in above line items:        
Cost of licensing0.7  0.6   3.1   2.4   
Cost of products and services0.9  1.2   3.6   3.1   
Research and development0.1  0.1   0.7   0.2   
Sales and marketing0.8  1.3   3.3   4.2   
General and administrative  (0.1)  —   —   
      
Diluted earnings per share:Fiscal Quarter Ended Fiscal Year Ended
 September 25,
2020
September 27,
2019
 September 25,
2020
September 27,
2019
GAAP diluted earnings per share$0.26  $0.43   $2.25  $2.44  
Stock-based compensation0.21  0.17   0.84  0.73  
Amortization of acquisition-related intangibles0.03  0.03   0.10  0.09  
Restructuring charges  0.06   0.02  0.35  
Impact of Tax Reform       (0.17) 
Income tax adjustments(0.05) (0.03)  (0.24) (0.24) 
Non-GAAP diluted earnings per share$0.45  $0.66   $2.97  $3.20  
      
      
Shares used in computing diluted earnings per share103  103   103  105  
      
The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial amounts for the first quarter of fiscal 2021 included in this release:
      
Gross margin:    Q1 2021
GAAP gross margin (low - high end of range)    90% - 91%
Stock-based compensation    0.2 %
Amortization of acquisition-related intangibles    0.8 %
Non-GAAP gross margin (low - high end of range)    91% - 92%
      
Operating expenses:    Q1 2021
GAAP operating expenses (low - high end of range)    $207 - $219
Stock-based compensation    (24) 
Amortization of acquisition-related intangibles    (1) 
Restructuring charges, net    (7)  - (9)
Non-GAAP operating expenses (low - high end of range)    $175 - $185
      
Diluted earnings per share:  Q1 2021
    LowHigh
GAAP diluted earnings per share   $0.70  $0.85  
Stock-based compensation   0.23  0.23  
Amortization of acquisition-related intangibles   0.03  0.03  
Restructuring charges, net   0.08  0.08  
Income tax adjustments   (0.07) (0.07) 
Non-GAAP diluted earnings per share   $0.97  $1.12  
      
Shares used in computing diluted earnings per share   103  103  


Investor Contact:
Jason Dea
Dolby Laboratories, Inc.
415-357-7002
investor@dolby.com

Media Contact:
Karen Hartquist
Dolby Laboratories, Inc.
415-505-8357
karen.hartquist@dolby.com

 

FAQ

What were Dolby's Q4 2020 revenue and earnings?

Dolby's Q4 2020 revenue was $271.2 million, with GAAP net income of $26.8 million, or $0.26 per diluted share.

How did Dolby's fiscal 2020 results compare to 2019?

For fiscal 2020, Dolby reported revenue of $1.16 billion and GAAP net income of $231.4 million, down from $1.24 billion and $255.2 million in 2019.

Is Dolby paying a dividend, and what is the amount?

Yes, Dolby announced a cash dividend of $0.22 per share, payable on December 4, 2020.

How is COVID-19 impacting Dolby's business?

COVID-19 has led to revenue declines across various markets, and Dolby expects continued uncertainty in future results.

What is Dolby's financial outlook for fiscal 2021?

Dolby anticipates ongoing uncertainty regarding unit shipments and the global cinema market due to COVID-19's impact.

Dolby Laboratories, Inc.

NYSE:DLB

DLB Rankings

DLB Latest News

DLB Stock Data

7.56B
58.87M
1.48%
93.98%
0.93%
Specialty Business Services
Patent Owners & Lessors
Link
United States of America
SAN FRANCISCO